Tag Archive for: ketamine
First-Of-Its-Kind Ketamine Prescribing Service Now Available to Psychotherapists
TreatmentA new first-of-its-kind ketamine prescribing service comes to independent psychotherapists using the dissociative with their patients.
Extended-Release Ketamine Effective in Patients With Treatment-Resistant Depression
TreatmentKetamine may offer new hope for sufferers of treatment resistant depression via an extended-release oral administered option.
Bringing Next-Gen Depression Treatment to Market: PharmaTher’s Ketamine Patch
ResearchPsychedelic biotech company PharmaTher says its ketamine patch could help relieve depression better than other treatments.
University of Calgary Creates Canada’s First Chair for Psychedelic Research
ResearchCanada gets its first chair for psychedelic research thanks to private citizen funding to the University of Calgary.
Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of Ketamine
ResearchA new device may help Cybin better understand the psychedelic impact of the drug ketamine on the human brain.
FDA Green-Lights Ketamine Study for Side Effects of Parkinson’s Disease Treatment
ResearchResearch into ketamine as a potential treatment for Parkinson's patients suffering from drug side effects is getting FDA approval.
New Treatment Potential for Depressed, Suicidal Patients With Ketamine, Says Expert
TreatmentThere's new hope for depressed and suicidal patients with ketamine therapy, says University of Alabama doctor Richard C. Shelton.
NIMH Supports 8 Interventions for Severe Suicide Risk Including Ketamine, Esketamine
ResearchNew treatment interventions approved by NIMH for use with high-suicide risks include two novel ketamine therapies.
Ketamine Effectively Treats Persistent Migraine Headaches: Study
TreatmentA nasal spray of ketamine proved to be highly effective at treating a type of migraine called refractory migraines, according to a new study.
PharmaTher Files Patent on Ketamine for Diabetes and Obesity Treatment
TreatmentKetamine may be a useful treatment for diabetes and obesity, according to a new patent filed by psychedelic company PharmTher.